Prelude Capital Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$1.2 - $6.66 $1,299 - $7,212
-1,083 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$5.35 - $7.11 $5,794 - $7,700
1,083 New
1,083 $7,000
Q3 2018

Nov 14, 2018
SELL
$10.32 - $13.06 $12,384 - $15,672
-1,200 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$7.8 - $13.69 $9,360 - $16,428
1,200 New
1,200 $14,000

Others Institutions Holding LXRX

# of Institutions
131
Shares Held
240M
Call Options Held
617K
Put Options Held
286K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $310M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email